Stage III Esophageal Adenocarcinoma

Known as: Stage III Adenocarcinoma of the Esophagus, Stage III Esophagus Adenocarcinoma, Stage III Adenocarcinoma of Esophagus 
Stage III includes: IIIA (T1-2, N2, M0, Any G); (T3, N1, M0, Any G); (T4a, N0, M0, Any G); IIIB (T3, N2, M0, Any G); IIIC (T4a, N1-2, M0, Any G… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2013
01220042013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Experience with neoadjuvant chemoradiation (CXRT) has raised questions regarding the additional benefit of surgery after locally… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2012
Review
2012
The treatment of localized esophageal cancer has been debated controversially over the past decades. Neoadjuvant treatment was… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2011
2011
OBJECTIVE A complete pathologic response to neoadjuvant chemotherapy, without the use of radiation, has infrequently been… (More)
Is this relevant?
2011
2011
Chemotherapy-induced peripheral neuropathy (CIPN) is a common, miserable, potentially severe, and often dose-limiting side effect… (More)
Is this relevant?
2006
2006
4054 Background: A Phase II trial to evaluate neoadjuvant (NAD) and adjuvant (AD) combination chemotherapy (CT) without radiation… (More)
Is this relevant?
2004
2004
BACKGROUND The optimal treatment for locally advanced esophageal cancer remains controversial. The objective of this study was to… (More)
Is this relevant?